Rational combination therapy for type 2 diabetes

Lancet Diabetes Endocrinol. 2019 May;7(5):328-329. doi: 10.1016/S2213-8587(19)30069-5. Epub 2019 Mar 1.

Author

Stefano Del Prato¹

Affiliation

¹ Department of Clinical & Experimental Medicine, University of Pisa, Pisa 56124, Italy. Electronic address: stefano.delprato@med.unipi.it.

PMID: 30833171
DOI: 10.1016/S2213-8587(19)30069-5

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2*
Glucagon-Like Peptides
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
semaglutide
Glucagon-Like Peptides